| 1 |
34929248 | Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling. | 2022 Jan |
1 |
| 2 |
33671112 | An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β/β-Catenin/STAT3/CD44 Suppressor with Anti-Glioblastoma Properties. | 2021 Feb 28 |
1 |
| 3 |
33774344 | Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide. | 2021 Jun 5 |
3 |
| 4 |
34204596 | Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer. | 2021 Jun 12 |
1 |
| 5 |
34429248 | Niclosamide affects intracellular TDP-43 distribution in motor neurons, activates mitophagy, and attenuates morphological changes under stress. | 2021 Dec |
1 |
| 6 |
34434118 | TRIM18-Regulated STAT3 Signaling Pathway via PTP1B Promotes Renal Epithelial-Mesenchymal Transition, Inflammation, and Fibrosis in Diabetic Kidney Disease. | 2021 |
1 |
| 7 |
31894334 | Niclosamide inhibits the cell proliferation and enhances the responsiveness of esophageal cancer cells to chemotherapeutic agents. | 2020 Feb |
2 |
| 8 |
31950153 | Niclosamide suppresses macrophage-induced inflammation in endometriosis†. | 2020 Apr 24 |
2 |
| 9 |
33002501 | Noncanonical pS727 post translational modification dictates major STAT3 activation and downstream functions in breast cancer. | 2020 Nov 15 |
1 |
| 10 |
33011217 | Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancer. | 2020 Dec 1 |
3 |
| 11 |
30329025 | Endometriotic inflammatory microenvironment induced by macrophages can be targeted by niclosamide†. | 2019 Feb 1 |
2 |
| 12 |
30348020 | Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells. | 2019 Feb |
1 |
| 13 |
30779072 | EGF promotes HIF-1α expression in colorectal cancer cells and tumor metastasis by regulating phosphorylation of STAT3. | 2019 Feb |
3 |
| 14 |
31243136 | Pentagalloylglucose Inhibits the Replication of Rabies Virus via Mediation of the miR-455/SOCS3/STAT3/IL-6 Pathway. | 2019 Sep 15 |
1 |
| 15 |
31371076 | CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma. | 2019 Aug |
1 |
| 16 |
31383893 | Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6/STAT3 signalling axis. | 2019 Aug 5 |
2 |
| 17 |
31451218 | STAT3 operates as a novel transcription factor that regulates NEDD4 in Keloid. | 2019 Oct 22 |
3 |
| 18 |
31465777 | Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway. | 2019 Nov |
4 |
| 19 |
31611940 | Platelet-derived growth factor-BB promotes proliferation and migration of retinal microvascular pericytes by up-regulating the expression of C-X-C chemokine receptor types 4. | 2019 Nov |
1 |
| 20 |
28389414 | Niclosamide: Beyond an antihelminthic drug. | 2018 Jan |
1 |
| 21 |
29251334 | Niclosamide acts as a new inhibitor of vasculogenic mimicry in oral cancer through upregulation of miR-124 and downregulation of STAT3. | 2018 Feb |
4 |
| 22 |
29278854 | Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma. | 2018 Feb |
1 |
| 23 |
29545902 | JAK2/STAT3 pathway as a therapeutic target in ovarian cancers. | 2018 Apr |
3 |
| 24 |
29603892 | Niclosamide, a Drug with Many (Re)purposes. | 2018 Jun 6 |
1 |
| 25 |
29721216 | Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer. | 2018 Apr 10 |
1 |
| 26 |
29783777 | Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer. | 2018 May 20 |
1 |
| 27 |
29855616 | Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide. | 2018 Sep |
4 |
| 28 |
30125275 | The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR. | 2018 Aug |
2 |
| 29 |
30272302 | Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer. | 2018 Dec |
1 |
| 30 |
30519314 | Niclosamide Inhibits Cell Growth and Enhances Drug Sensitivity of Hepatocellular Carcinoma Cells via STAT3 Signaling Pathway. | 2018 |
3 |
| 31 |
28367059 | Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer. | 2017 |
4 |
| 32 |
28877265 | Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line. | 2017 |
1 |
| 33 |
29031202 | Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells. | 2017 Dec |
4 |
| 34 |
26792726 | Niclosamide suppresses RANKL-induced osteoclastogenesis and prevents LPS-induced bone loss. | 2016 Feb 5 |
1 |
| 35 |
27449264 | WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. | 2016 Nov |
2 |
| 36 |
27545321 | Defined Host-Guest Chemistry on Nanocarbon for Sustained Inhibition of Cancer. | 2016 Nov |
1 |
| 37 |
27793003 | Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors. | 2016 Nov 22 |
1 |
| 38 |
27888804 | Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer. | 2016 Dec 27 |
1 |
| 39 |
25970160 | Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition. | 2015 Sep |
4 |
| 40 |
26434865 | Bevacizumab Regulates Cancer Cell Migration by Activation of STAT3. | 2015 |
1 |
| 41 |
26716739 | [Molecular mechanisms of niclosamide antitumor activity]. | 2015 Nov-Dec |
1 |
| 42 |
24362463 | Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer. | 2014 Mar |
4 |
| 43 |
24732808 | Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. | 2014 Jul 10 |
1 |
| 44 |
24945434 | STAT3 modulation to enhance motor neuron differentiation in human neural stem cells. | 2014 |
2 |
| 45 |
23459613 | Discovery of O-Alkylamino Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents. | 2013 Feb 14 |
1 |
| 46 |
23894143 | Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer. | 2013 Oct |
2 |
| 47 |
24019973 | Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer. | 2013 |
4 |
| 48 |
22237038 | Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells. | 2012 Apr |
1 |
| 49 |
22829072 | Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production. | 2011 Oct |
1 |
| 50 |
24900231 | Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway. | 2010 Dec 9 |
2 |